AbbVie’s Deal Spree Enriches its Pipeline with Oncology Assets
By Taskin Ahmed & Jasmine Kalsi
Pharma Deals Review: Vol 2016 Issue 5 (Table of Contents)
Published: 7 May-2016
DOI: 10.3833/pdr.v2016.i5.2158 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to bolster its oncology pipeline, AbbVie entered into multiple agreements focusing on targeted monoclonal antibodies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS